Satellite Symposia

Satellite symposia are organised by industrial companies and take place at lunchtime as well as in the morning and in the evening in order to avoid time conflicts with the main scientific programme. During these sessions cutting-edge information on interventional equipment and techniques is provided.

Wednesday, July 21

               11:30-12:15
SY 301    Bracco                                            Main Auditorium
               Role of contrast enhanced ultrasound in the
               diagnosis and treatment of tumours 

               Moderator: E. Leen (London/UK)

301.1       Quantification of tumour microvascularity using CEUS
               modality for monitoring anti-angiogenic therapies 
               E. Leen (London/UK)
301.2       CEUS-guided percutaneous radiofrequency ablation of
               breast cancer liver metastases
               M.F. Meloni (Monza/IT)
301.3       New perspectives in interventional contrast ultrasound
               imaging: 3D contrast and multi-modality fusion imaging
               L. Solbiati (Busto Arsizio/IT) 


               12:15-13:00
SY 302    CeloNova                                         Main Auditorium
               Targeted embolization in liver pathologies with
               Embozene™ Color-Advanced Microspheres

               Moderator: J.G. Caridi (Gainesville, FL/US)

302.1       Multipurpose use of Embozene™ Color-Advanced
               Microspheres in clinical practice
               F. Orsi (Milan/IT) 
302.2       The concept of liver tumor embolization with 40 µm
               Embozene™ Color-Advanced Microspheres
               T.K. Helmberger (Munich/DE)
302.3       Portal vein embolization: experience with various spherical
               embolic agents
               M. Wallace (Houston, TX/US) 


               17:30-18:00
SY 601    Covidien                                           Sala Verde
               RFA and MWA: The Power of Choice

               Moderator: J. Case (Boulder, CO/US)

601.1       Clinical applications of multiple RFA electrode technology
               A. Gillams (London/UK)
601.2       MWA of liver metastases
               T. Lorentzen (Herlev/DK)


               17:30-18:00
SY 602    Terumo                                             Main Auditorium
               Pre Radioembolization coiling, the added value of
               Hydrocoils

               Moderator: G. Maleux (Leuven/BE)

602.1       Watertight GDA embolization
               S.C. Rose (San Diego, CA/US)
602.2       Azur, One year experience at Grosshadern Hospital
               R.-T. Hoffmann (Munich/DE)

Thursday, July 22

               11:30-12:15
SY 901    Terumo                                             Main Auditorium
               Drug-eluting beads: what's new?

               Moderator: M. Burrel (Barcelona/ES)

901.1       Results from a prospective randomized comparison of
               chemoembolization with DC Bead versus bland
               embolization for HCC
               K. Malagari (Athens/GR)
901.2       Irinotecan-eluting beads as a neoadjuvant treatment of
               colorectal liver metastases in resectable patients
               E.A. O’Grady (Liverpool/UK)
901.3       DC Beads for the treatment of liver metastases from
               melanoma: new application?
               P. Pereira (Heilbronn/DE) 
901.4       DC Beads for the treatment of liver metastases from
               occular Melanoma: tips and tricks from more than
               50 patients experience in Ferrara center
               C. Aliberti (Lagosanto/IT)


               12:15-13:00
SY 902    Biocompatibles                                 Main Auditorium
               LC/DC Bead - how to select patients and optimise
               outcomes 

               Moderator: R. Lencioni (Pisa/IT)

902.1       Technical aspects of hepatocellular carcinoma. How to
               do it.
               J.G. Caridi (Gainesville, FL/US)
902.2       Technical aspects of metastatic diseases. How to do it. 
               G. Narayanan (Miami, FL/US)
902.3       DC Bead in metastatic disease. DEBIRI in combination
               with systemic chemotherapy: the optimal management
               of liver dominant metastatic disease
               R.C. Martin (Louisville, KY/US) 


               17:30-18:15
SY 1201  AngioDynamics                                 Main Auditorium
               Irreversible electroporation: the next frontier for 
               focal ablative therapy
               Early human experience at three centers

               Moderator: R. Lencioni (Pisa/IT)

1201.1     IRE: moving from bench investigation to clinical experience
               R. Lencioni (Pisa/IT)
1201.2     The University of Miami experience with the Nanoknife
               G. Narayanan (Miami, FL/US)
1201.3     Non-thermal ablation using irreversible electroporation
               (IRE): initial U.S. clinical experience
               R.C. Martin (Louisville, KY/US)

Friday, July 23

               11:30-12:15
SY 1501  Sirtex                                                Main Auditorium
               Broadening the horizon: why choose
               radioembolization over other options?

               Moderator: G. Maleux (Leuven/BE)

1501.1     The compelling evidence base for unresectable liver
               metastases
               T.F. Jakobs (Munich/DE)
1501.2     Expanding the cohort of patients with primary liver tumours
               receiving radioembolization
               J.I. Bilbao (Pamplona/ES) 


               12:15-13:00
SY 1502  Siemens                                            Main Auditorium
               Image-guided solutions for
               interventional oncology
               Minimally invasive, maximally effective

               Moderator: R. Lencioni (Pisa/IT)

1502.1     The benefits of Artis zeego during liver tumour treatment 
               T.F. Jakobs (Munich/DE)
1502.2     New approaches in cancer diagnostics and CT-guided
               interventions
               A. Schmid (Erlangen/DE) 


               18:00-18:30
SY 1801  Celon                                                 Main Auditorium
               RFITT - The Celon Method
               Large homogeneous ablation volumes by use of
               multiapplicator devices

               Moderator: T. Albrecht (Berlin/DE)

1801.1     Multipolar RFA of liver metastases - principles and clinical
               results
               T. Albrecht (Berlin/DE) 


               18:00-18:30
SY 1802  Bayer Schering Pharma                    Sala Verde
               Managing intermediate- and advanced-stage HCC
               patients

               Moderator: T. De Baère (Villejuif/FR)

1802.1     Building on the experience with sorafenib in
               advanced-stage HCC: an hepatologist's
               perspective
               M. Colombo (Milan/IT)
1802.2     Evolving strategies in intermediate-stage HCC: where are
               we now?
               T. De Baère (Villejuif/FR)